Get instant access to this report sample and gain complimentary access to our procurement research platform.
Trusted by
The pharmaceutical contract manufacturing procurement category is projected to grow at a CAGR of 6.89% during 2023-2027. The prices are outlined to rise by 5%-8% during the forecast period and suppliers will have a moderate bargaining power in this market. Pfizer Inc., C.H. Boehringer Sohn AG and Co. KG, and Baxter International Inc. are a few of the key suppliers in pharmaceutical contract manufacturing market.
To unlock the YoY growth values for 2023-2027, Request for a FREE Sample Report!
This report offers detailed insights and analysis of the major cost drivers, volume drivers, and innovations of the pharmaceutical contract manufacturing procurement and sourcing market, which the global suppliers have been leveraging to gain a competitive edge across regions. Some of the leading pharmaceutical contract manufacturing suppliers profiled extensively in this report include:
Furthermore, this pharmaceutical contract manufacturing procurement market report provides a detailed analysis of procurement strategies deployed by major category end-users across several industries while sourcing for pharmaceutical contract manufacturing requirements. In addition, most adopted and high-potential pricing models considered by buyers have been analyzed in this report, which will help understand business scopes for revenue expansion. These data will assist buyers to realize cost savings and identify business strategies to improve sales.
The pharmaceutical contract manufacturing procurement market report provides a detailed analysis into various supplier selection criteria, RFX questions, supplier evaluation metrics, and the service level agreements that the buyers should consider adopting to achieve significant cost savings, streamline the procurement process, and reduce category TCO while sourcing for pharmaceutical contract manufacturing requirements.
To get the exact category management parameters and unfold their degree of influence on this pharmaceutical contract manufacturing procurement market in details, Get the FREE Sample Report Now!
The report provides a detailed insight of the most adopted procurement strategies by buyers across industries and an analysis of these strategies with respect to innovation, regulatory compliance, quality, supply, and cost. Adoption of these procurement strategies will enable the buyers to reduce category TCO and achieve cost savings while sourcing for pharmaceutical contract manufacturing requirements.
The report discusses in detail each pricing model and the pros and cons attached to every pricing model prevalent in the market. Also, the report provides insights with respect to the category supply chain and the margins of various suppliers within the supply chain. These market analysis data will enable the buyers to make informed strategic sourcing decisions. Buy the full pharmaceutical contract manufacturing procurement market report now to get comprehensive details on pricing models
Request for a FREE sample to access the latest price forecasts, market drivers, and TCO reduction opportunites for the pharmaceutical contract manufacturing market
To optimize the value of the purchase, it is crucial to keep a track of current and future price trends. Price forecasts are beneficial in purchase planning, especially when supplemented by the constant monitoring of price influencing factors. During the forecast period, the market expects an incremental spend of USD 64.21 billion due to various market drivers prevalent across multiple regions. Also, the report speaks about various cost-saving factors through analysis of the below factors:
The pharmaceutical contract manufacturing market will register an incremental spend of about USD 64.21 billion during the forecast period. However, only a few regions will drive the majority of this growth. Moreover, on the supply side, North America, Europe, and APAC will have the maximum influence owing to the supplier base. The growth is expected to be primarily driven by increasing demand and adoption of the category across those few regions. To get a detailed analysis of the volume drivers that are driving the adoption of the category across regions, buy the full report now!
The drivers and inhibitors that influence these global and regional outlooks are elaborated in detail in this procurement report. Our in-depth growth decomposition analysis covers details on:
Request for a FREE sample for more information on the spend growth for pharmaceutical contract manufacturing procurement market
A targeted strategic approach to pharmaceutical contract manufacturing sourcing will provide several opportunities. However, in the absence of actionable intelligence on pharmaceutical contract manufacturing, buyers may end up focusing on a tactical sourcing strategy without any focus on cost-saving opportunities. Hence, this report focuses on category management initiatives such as top-line growth, scalability of inputs, and green initiatives, which will assist buyers to formulate a strategic procurement strategy
The report explains the following key category management objectives that should form the base for sourcing strategy.
To explore the extent of influence of category management objectives that can improve the efficiencies of the retailers, Request for a FREE Sample Report!
In addition to helping buyers in identifying the strategic goals and initiatives for category management, the report also has detailed insights into the most outsourced category management activities and category enablers which can simplify the procurement process for buyers.
|
Scope of Pharmaceutical Contract Manufacturing |
|
|
Report Specs |
Details |
|
Page number |
150 |
|
Base year |
2022 |
|
Forecast period |
2023-2027 |
|
Spend growth (CAGR) |
6.89% |
|
Incremental spend |
USD 64.21 billion |
|
Pricing growth outlook |
5%-8% |
|
Pricing models |
Volume-based pricing model, Value-based pricing model, and Project-based pricing model |
|
Supplier selection scope |
Domain expertise and experience, Scalability and flexibility, Regulatory compliance, and Time-to-market |
|
Supplier opportunities |
Top-line growth, Scalability of inputs, Green initiatives, Category innovations, Supply base rationalization, Demand forecasting and governance, Minimalization of ad hoc purchases, Adherence to regulatory nuances, Cost savings, Reduction of TCO, Supply assurance, and Customer retention |
|
Supplier selection criteria |
Business needs, Technical specifications, Operational requirements, Security compliance, Regulatory mandates, Legal requirements, Quality control, Change management procedures, Pricing models, Penalty clauses, SLA nuances, Acceptance criteria, and Evaluation criteria |
|
Category management scope |
Top-line growth, Scalability of inputs, Green initiatives, Category innovations, Supply base rationalization, Demand forecasting and governance, Minimalization of ad hoc purchases, Adherence to regulatory nuances, Cost savings, Reduction of TCO, Supply assurance, and Customer retention |
|
Top suppliers |
Pfizer Inc., C.H. Boehringer Sohn AG and Co. KG, Baxter International Inc., Recipharm AB, Thermo Fisher Scientific Inc., Catalent Inc., Aenova Holding GmbH, Jubilant Pharmova Ltd., FAMAR Health Care Services, and Lonza Group Ltd. |
|
Market dynamics |
Regional category spend in terms of percentage with respect to North America, South America, Europe, Middle East and Africa and APAC and global category spend and CAGR in terms of percentage over a span of 5 years. |
|
Customization scope |
We can create customized sourcing/procurement reports with specific requirements for your business. |
Request for a FREE sample now!
Copyright © 2024 Infiniti Research Limited. All Rights Reserved. Privacy Notice – Terms of Use – Sales and Subscription
